Cardiovascular and renal outcomes with empagliflozin in heart failure

Medicine and Dentistry

• Heart Failure 90%
• Empagliflozin 90%
• Patient 50%
• Cardiovascular System 40%
• Inpatient 30%
• Absence 30%
• Combination Therapy 20%
• Hazard Ratio 20%
• Ejection Fraction 20%
• Drug 10%
• Chemotherapeutic Agent 10%
• Amaurosis 10%
• Glomerular Filtration Rate 10%
• Deterioration 10%
• Body Surface 10%
• Sodium Glucose Cotransporter 2 Inhibitor 10%
• Genital Tract Infection 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Heart Failure 90%
• Empagliflozin 90%
• Diabetes Mellitus 30%
• Absence 30%
• Death 30%
• Drug 10%
• Blindness 10%
• Sodium Glucose Cotransporter 2 Inhibitor 10%
• Genital Tract Infection 10%